The global peri-implantitis market was valued at USD 1,071.6 Million in 2024 and is projected to reach USD 2,087.3 Million by 2033, growing at a CAGR of 7.69% during 2025-2033. Market growth is driven by growing awareness, an aging population demanding dental implants, technological improvements, and increasing collaborations in the dental implant industry. This rising demand promotes advancements in aesthetic dental implant treatments and infrastructure globally. 

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Peri-Implantitis Market Key Takeaways

• Current Market Size: USD 1,071.6 Million in 2024
• CAGR: 7.69% (2025-2033)
• Forecast Period: 2025-2033
• The market is driven by shifting consumer preference toward aesthetic dental implants and collaborations among manufacturers, providers, and research institutions.
• Continual healthcare infrastructure improvements increase dental implant procedure accessibility.
• Surgical methods dominate market share over non-surgical owing to precision and thorough debridement benefits.
• Hospitals are the largest end-user segment due to multidisciplinary approaches and advanced diagnostic capabilities.
• Europe holds the largest regional market share because of its robust healthcare infrastructure and pioneering research institutions.

Request for a Free Sample of this Report: https://www.imarcgroup.com/peri-implantitis-market/requestsample

Market Growth Factors

The global peri-implantitis market growth is propelled by several key factors. Firstly, shifting consumer preferences towards aesthetic dental implants significantly contribute to market expansion. Patients increasingly seek dental implants for their natural appearance and improved quality of life. The aging global population also drives demand for dental implants, as older individuals require such solutions to enhance oral function and aesthetics. With increased dental implant procedures, the risk of peri-implantitis rises, necessitating effective treatments and solutions, further spurring market growth.

Technological advancements in dental implants have revolutionized the treatment of peri-implantitis. Innovations in implant design, biocompatible materials such as titanium alloys and zirconia, and antibacterial surface coatings lower the risk of infection and enhance treatment outcomes. These developments attract patients and dental professionals alike, encouraging market growth. Moreover, non-surgical and surgical treatment improvements allow precision in accessing and treating infected implant sites, promoting healing, and reducing recovery time, which supports wider adoption of peri-implantitis management methods.

Additionally, improving healthcare infrastructure in emerging economies increases patient access to dental implant procedures. The increasing number of collaborations among dental implant manufacturers, healthcare providers, and research institutions fosters the development of innovative products and treatment protocols. This collaboration accelerates knowledge exchange and the introduction of novel techniques for peri-implantitis management. Furthermore, the rise of dental tourism offers cost-effective dental care options, enhancing market growth by expanding the patient base worldwide and promoting improved treatments and preventative care.

Market Segmentation

By Method Type:

• Surgical:
• Bone Regeneration: Techniques aimed at regenerating bone tissue around implants to restore stability.
• Open Flap Debridement: Surgical exposure and cleaning of implant surfaces to remove infection.
• Implantoplasty: Physical modification and smoothening of implant surfaces to reduce bacterial accumulation.
• Non-Surgical:
• Mechanical Debridement: Non-invasive cleaning procedures to remove plaque and debris from implants.
• Laser Debridement: Use of laser technology to disinfect and clean implant areas.
• Antibiotics: Medication to control infection and inflammation around implants.
• Others: Additional non-surgical approaches employed for peri-implantitis treatment.

Surgical methods dominate due to precision access and thorough tissue decontamination, promoting effective treatment. Non-surgical methods are cost-effective, less invasive, and emphasize patient education and oral hygiene.

By End User:

• Hospitals: Equipped with diverse healthcare professionals and advanced diagnostic tools to provide multidisciplinary peri-implantitis management.
• Dental Clinics: Widespread and accessible facilities staffed by skilled dental professionals providing timely treatment and follow-up care.
• Others: Not specifically defined in the report.

Hospitals dominate owing to comprehensive, collaborative care and access to state-of-the-art technology.

By Region:

• North America: Includes the United States and Canada.
• Europe: Comprises Germany, France, the United Kingdom, Italy, Spain, and others.
• Asia Pacific: Includes China, Japan, India, South Korea, Australia, Indonesia, and others.
• Latin America: Brazil, Mexico, and others.
• Middle East and Africa: Not further broken down.

Regional Insights

Europe exhibits clear dominance in the peri-implantitis market, accounting for the largest market share. This supremacy is attributed to its robust healthcare infrastructure, including modern medical facilities and specialized dental departments within hospitals. The region leads in technological innovation with cutting-edge diagnostic tools aiding effective peri-implantitis management. Moreover, Europe hosts renowned research institutions driving advancements in implantology and prevention strategies, supported by a highly skilled dental workforce.

Key Players

• botiss biomaterials GmbH
• Geistlich Pharma AG
• Silveraid S.r.l.
• Straumann Holding AG

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.

Ask Our Expert & Browse Full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=11686&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302